Moreover, higher serum IL-13 levels and the presence of PD-L2 rs7854413 C allele carriers were associated with advanced fibrosis progression in NASH patients (OR 1.432 and 3.797 p < 0.01). Here, PDCD1LG2 is linked to metabolic dysfunction-associated steatohepatitis.